TCI Wealth Advisors, Inc. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 167 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.6%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2018$125,000
-12.0%
6,0000.0%0.05%
-17.5%
Q2 2018$142,000
+94.5%
6,000
+20.0%
0.06%
+85.3%
Q1 2018$73,000
+128.1%
5,000
+150.0%
0.03%
+142.9%
Q4 2017$32,000
-61.9%
2,000
-66.7%
0.01%
-65.9%
Q3 2017$84,000
+90.9%
6,000
+20.0%
0.04%
+86.4%
Q2 2017$44,0005,0000.02%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
RP Management, LLC 4,373,178$371,851,00055.73%
Avoro Capital Advisors LLC 26,250,000$2,232,038,00031.71%
Twin Securities, Inc. 467,761$39,774,00028.60%
Palo Alto Investors LP 4,852,383$412,598,00022.65%
Sand Grove Capital Management LLP 470,000$39,964,00021.19%
Beryl Capital Management LLC 1,046,632$88,995,00016.02%
Western Standard LLC 158,065$13,440,00015.26%
One68 Global Capital, LLC 60,990$5,186,00013.76%
First Light Asset Management, LLC 1,577,880$134,167,00013.75%
Boxer Capital, LLC 4,500,000$382,635,00013.22%
View complete list of IMMUNOMEDICS INC shareholders